Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold ...

GlaxoSmithKline will purchase Novartis’ 36.5 percent stake in their consumer healthcare joint venture for $13 billion, according to Reuters. Here are four things to know. 1. The $13 billion ...

On Saturday Unilever confirmed its interest in purchasing the division, a joint venture between GSK and Pfizer which owns brands including Sensodyne toothpaste, Centrum multivitamins and Advil ...

Novartis has completed a series of transactions with GlaxoSmithKline plc (GSK), including the acquisition of certain oncology products and pipeline compounds from GSK, the creation of a world-leading ...

LONDON (AP) — The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint ...

SHANGHAI/WASHINGTON (Reuters) - A U.S. anti-bribery probe into GlaxoSmithKline Plc touched on the firm's Chinese consumer healthcare business in 2012, internal documents show, suggesting the drugmaker ...

GlaxoSmithKline appointed Brian McNamara CEO of the Consumer Healthcare division. 1. Mr. McNamara most recently served as head of Europe and the Americas at GSK Consumer Healthcare. 2. Prior to ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

The MarketWatch News Department was not involved in the creation of this content. Paley Brings Over 25 Years of Leadership Experience Across Consumer Healthcare and Wellness at Haleon, GSK, Pfizer and ...

LONDON (Reuters) - Consumers from New York to New Delhi are digging deeper in their pockets for over-the-counter remedies and health products, a trend GlaxoSmithKline is banking on to help shape the ...